{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:02:41Z","timestamp":1789437761741,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014882","name":"Hebei Provincial Department of Finance","doi-asserted-by":"crossref","award":["ZF202518"],"award-info":[{"award-number":["ZF202518"]}],"id":[{"id":"10.13039\/501100014882","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003787","name":"Hebei Natural Science Foundation","doi-asserted-by":"crossref","award":["H2022206410"],"award-info":[{"award-number":["H2022206410"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Science Research Project of Hebei","award":["20250118"],"award-info":[{"award-number":["20250118"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04436-x","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:08:22Z","timestamp":1782720502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CLTC expression in oral squamous cell carcinoma: insights into prognostic value and immune microenvironment modulation"],"prefix":"10.1186","volume":"24","author":[{"given":"Zifeng","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaige","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaicheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"1","key":"4436_CR1","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"4436_CR2","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.2147\/IJN.S365594","volume":"17","author":"H Liu","year":"2022","unstructured":"Liu H, et al. Current status, opportunities, and challenges of exosomes in oral cancer diagnosis and treatment. Int J Nanomedicine. 2022;17:2679\u2013705.","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"4436_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1177\/0022034520986551","volume":"100","author":"S Sun","year":"2021","unstructured":"Sun S, et al. MiR-302b suppresses tumor metastasis by targeting Frizzled 6 in OSCC. J Dent Res. 2021;100(7):739\u201345.","journal-title":"J Dent Res"},{"key":"4436_CR4","doi-asserted-by":"publisher","first-page":"1770711","DOI":"10.3389\/fimmu.2026.1770711","volume":"17","author":"Y Wang","year":"2026","unstructured":"Wang Y, et al. The value of Protein Phosphatase Methylesterase 1 in diagnosis, prognosis and immunoregulation: from pan-cancer analysis to breast cancer verification. Front Immunol. 2026;17:1770711.","journal-title":"Front Immunol"},{"key":"4436_CR5","first-page":"1439","volume":"17","author":"Y Gou","year":"2025","unstructured":"Gou Y, et al. Integrated pan-cancer profiling and breast cancer validation identify BEND3 as a potential prognostic and immune biomarker. Breast Cancer (Dove Med Press). 2025;17:1439\u201361.","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"4436_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1670526","volume":"15","author":"D Elihamu","year":"2025","unstructured":"Elihamu D, et al. CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation. Front Oncol. 2025;15:1670526.","journal-title":"Front Oncol"},{"key":"4436_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1667589","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, et al. CLIC6\u2019s role in cancer: from broad analysis to breast cancer validation. Front Oncol. 2025;15:1667589.","journal-title":"Front Oncol"},{"issue":"7","key":"4436_CR8","doi-asserted-by":"publisher","first-page":"9045","DOI":"10.1007\/s13277-015-4629-y","volume":"37","author":"E Bagordakis","year":"2016","unstructured":"Bagordakis E, et al. Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures. Tumour Biol. 2016;37(7):9045\u201357.","journal-title":"Tumour Biol"},{"key":"4436_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111228","volume":"120","author":"F Song","year":"2024","unstructured":"Song F, et al. Lactylome analyses suggest systematic lysine-lactylated substrates in oral squamous cell carcinoma under normoxia and hypoxia. Cell Signal. 2024;120:111228.","journal-title":"Cell Signal"},{"issue":"3s","key":"4436_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jormas.2024.101806","volume":"125","author":"A Farshbaf","year":"2024","unstructured":"Farshbaf A, et al. Clinical value and potential circulating of miR-99a as tumor suppressor biomarker in serum of oral squamous cell carcinoma and erosive atrophic lichen planus. J Stomatol Oral Maxillofac Surg. 2024;125(3s):101806.","journal-title":"J Stomatol Oral Maxillofac Surg"},{"issue":"2","key":"4436_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/omi.12491","volume":"40","author":"H Xiao","year":"2025","unstructured":"Xiao H, Li Y. From teeth to body: the complex role of Streptococcus mutans in systemic diseases. Mol Oral Microbiol. 2025;40(2):65\u201381.","journal-title":"Mol Oral Microbiol"},{"issue":"1","key":"4436_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12964-021-00800-4","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, et al. Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway. Cell Commun Signal. 2021;19(1):121.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"4436_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12967-021-03181-x","volume":"19","author":"JY Zhang","year":"2021","unstructured":"Zhang JY, et al. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness. J Transl Med. 2021;19(1):513.","journal-title":"J Transl Med"},{"key":"4436_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246299","author":"K Kawasaki","year":"2021","unstructured":"Kawasaki K, et al. Ginkgolide B regulates CDDP chemoresistance in oral cancer via the platelet-activating factor receptor pathway. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13246299.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4436_CR15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00784-017-2190-3","volume":"22","author":"B Lon\u010dar-Brzak","year":"2018","unstructured":"Lon\u010dar-Brzak B, et al. Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential. Clin Oral Investig. 2018;22(2):1071\u201382.","journal-title":"Clin Oral Investig"},{"issue":"1","key":"4436_CR16","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1038\/s41467-025-59004-w","volume":"16","author":"Z Xiang","year":"2025","unstructured":"Xiang Z, et al. Efficacy, safety and single-cell analysis of neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma: a phase II trial. Nat Commun. 2025;16(1):3968.","journal-title":"Nat Commun"},{"issue":"5","key":"4436_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12032-023-02010-z","volume":"40","author":"S Lenka","year":"2023","unstructured":"Lenka S, et al. Understanding the functional relevance of oral neutrophils, phenotype and properties in OSCC. Med Oncol. 2023;40(5):134.","journal-title":"Med Oncol"},{"issue":"7","key":"4436_CR18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1177\/00220345231165209","volume":"102","author":"LZ Zhang","year":"2023","unstructured":"Zhang LZ, et al. PD-1 carried on small extracellular vesicles leads to OSCC metastasis. J Dent Res. 2023;102(7):795\u2013805.","journal-title":"J Dent Res"},{"issue":"5","key":"4436_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2025.104670","volume":"46","author":"A Duan","year":"2025","unstructured":"Duan A, Zheng Y, Xiao G. Machine learning developed regulatory T cells-related signature for prognosis and immunotherapy benefit in oral squamous cell carcinoma. Am J Otolaryngol. 2025;46(5):104670.","journal-title":"Am J Otolaryngol"},{"issue":"5","key":"4436_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrm.2017.132","volume":"19","author":"M Kaksonen","year":"2018","unstructured":"Kaksonen M, Roux A. Mechanisms of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol. 2018;19(5):313\u201326.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"4436_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/cam4.3635","volume":"10","author":"B Kim","year":"2021","unstructured":"Kim B, et al. Clathrin-mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild-type EGFR non-small cell lung cancer. Cancer Med. 2021;10(1):372\u201385.","journal-title":"Cancer Med"},{"issue":"4","key":"4436_CR22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.yexcr.2008.07.029","volume":"315","author":"A Sorkin","year":"2009","unstructured":"Sorkin A, Goh LK. Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res. 2009;315(4):683\u201396.","journal-title":"Exp Cell Res"},{"issue":"7037","key":"4436_CR23","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/nature03502","volume":"434","author":"SJ Royle","year":"2005","unstructured":"Royle SJ, Bright NA, Lagnado L. Clathrin is required for the function of the mitotic spindle. Nature. 2005;434(7037):1152\u20137.","journal-title":"Nature"},{"issue":"1","key":"4436_CR24","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1038\/s41467-020-17090-y","volume":"11","author":"R Ben-Hamo","year":"2020","unstructured":"Ben-Hamo R, et al. Predicting and affecting response to cancer therapy based on pathway-level biomarkers. Nat Commun. 2020;11(1):3296.","journal-title":"Nat Commun"},{"key":"4436_CR25","doi-asserted-by":"crossref","unstructured":"Yang KS, et al. Propofol induces apoptosis and ameliorates 5\u2011fluorouracil resistance in OSCC cells by reducing the expression and\u00a0secretion of amphiregulin. Mol Med Rep. 2022;25(1):36.","DOI":"10.3892\/mmr.2021.12552"},{"issue":"1","key":"4436_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12916-024-03541-6","volume":"22","author":"W Jiang","year":"2024","unstructured":"Jiang W, et al. Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: a randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarker. BMC Med. 2024;22(1):314.","journal-title":"BMC Med"},{"issue":"2","key":"4436_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/odi.14017","volume":"29","author":"LY Almeida","year":"2023","unstructured":"Almeida LY, et al. FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1. Oral Dis. 2023;29(2):649\u201360.","journal-title":"Oral Dis"},{"issue":"24","key":"4436_CR28","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1111\/jcmm.17998","volume":"27","author":"S Wu","year":"2023","unstructured":"Wu S, et al. Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages. J Cell Mol Med. 2023;27(24):4133\u201344.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"4436_CR29","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.18632\/aging.202386","volume":"13","author":"D Li","year":"2021","unstructured":"Li D, et al. Oxaliplatin induces the PARP1-mediated parthanatos in oral squamous cell carcinoma by increasing production of ROS. Aging (Albany NY). 2021;13(3):4242\u201357.","journal-title":"Aging (Albany NY)"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04436-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:27:11Z","timestamp":1789435631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04436-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4436"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04436-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Medical Ethics Committee of the Fourth Hospital of Hebei Medical University (Approval No. 2024KY008).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"372"}}